Seki H, Kasahara Y, Ohta K, Saikawa Y, Sumita R, Yachie A, Fujita S, Koizumi S
Department of Nursing, School of Health Sciences, Faculty of Medicine, Kanazawa University, Kanazawa, Japan.
Chemotherapy. 1999 Jan-Feb;45(1):15-21. doi: 10.1159/000007160.
Among Haemophilus influenzae isolated from children with respiratory tract infections, the evolution of ampicillin resistance was investigated during 1996 and 1997 in Japan. beta-Lactamase production was assessed and minimum inhibitory concentrations (MICs) of eight antimicrobial agents were determined using a broth microdilution method in Mueller-Hinton-lysed horse blood medium. Of 74 H. influenzae, 11 strains (14.9%) produce beta-lactamase and were thus highly resistant to ampicillin (MIC of >4.0 microgram/ ml). In addition, moderate resistance to ampicillin, defined as an MIC of >==1.0 microgram/ml, was noted in 44.4% of all beta-lactamase-negative isolates. These beta-lactamase-negative ampicillin-resistant (BLNAR) organisms were resistant to other cephalosporins such as cefpodoxime and cefdinir, while beta-lactamase-producing strains were susceptible to them. Cefditoren, cefteram, and minocycline were active against all strains studied, whereas cefaclor and clarithromycin were inactive against all H. influenzae isolates in this study. Results indicate that BLNAR strains have emerged among children with respiratory tract infections in Japan.
在日本,于1996年至1997年期间对从患有呼吸道感染的儿童中分离出的流感嗜血杆菌进行了氨苄西林耐药性演变的研究。评估了β-内酰胺酶的产生情况,并采用肉汤微量稀释法在Mueller-Hinton裂解马血培养基中测定了8种抗菌药物的最低抑菌浓度(MIC)。在74株流感嗜血杆菌中,有11株(14.9%)产生β-内酰胺酶,因此对氨苄西林高度耐药(MIC>4.0微克/毫升)。此外,在所有β-内酰胺酶阴性分离株中,有44.4%的菌株对氨苄西林呈现中度耐药,定义为MIC≥1.0微克/毫升。这些β-内酰胺酶阴性氨苄西林耐药(BLNAR)菌株对其他头孢菌素如头孢泊肟和头孢地尼耐药,而产β-内酰胺酶的菌株对它们敏感。头孢妥仑、头孢特仑和米诺环素对所有研究菌株均有活性,而头孢克洛和克拉霉素在本研究中对所有流感嗜血杆菌分离株均无活性。结果表明,日本患有呼吸道感染的儿童中已出现BLNAR菌株。